News and Media
;
Landmark trial brings genomic testing to thousands of Ontarians with cancer
The Ontario-wide Cancer Targeted Nucleic Acid Evaluation (OCTANE) expanded the province’s capacity for next-generation sequencing to deliver personalized approaches to treat cancer Maddi was just 33 years old when she learned that her breast cancer had metastasized. She was told the standard-of-care treatment for metastatic breast cancer at the time in 2019 could help manage […]
Read the story
Jul 15, 2024
Caregiver brings father’s voice to cancer research
Jul 05, 2024
Ask a Cancer Researcher: How does a tumour’s genetics factor into cancer care?
Jul 03, 2024
Study identifies two critical genes in pancreatic tumours
Jun 26, 2024
New patient-centred system for brain cancer radiotherapy receives top honours at FACIT Falcons’ Fortunes
Jun 13, 2024
Ask a Cancer Researcher: Why is it so challenging to find a cure for cancer?
May 29, 2024
Ontario Institute for Cancer Research (OICR) applauds the Province's renewed funding commitment to cancer research
May 27, 2024
New 3CTN initiative aims to address barriers faced by underrepresented populations and expand clinical trial involvement
May 23, 2024
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics
May 16, 2024
Help us shape OICR's next five year strategic plan
May 14, 2024
Ask a Cancer Researcher: How can ultrasound be used to detect breast cancer?
May 03, 2024
A message from the President and Scientific Director on the passing of Andrea Redway
Apr 22, 2024
How two cancers make themselves harder to treat by suppressing the immune system
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.